Get started
Author

Gill Farrar

Observed names: Farrar G, Farrar, G, Farrar, Gill, G Farrar, G. Farrar, GILL FARRAR
Observed institutions: University of Geneva, Uppsala University, Centrum Wiskunde & Informatica, Forschungszentrum Jülich, University of Cologne, Lund University, Universitair Ziekenhuis Leuven, Amersham Hospital, General Electric (Canada), Maastricht University, Massachusetts General Hospital, Ixico (United Kingdom), Hermes Medical Solutions (Sweden), Amsterdam Neuroscience, Roche (United Kingdom), Centro San Giovanni di Dio Fatebenefratelli, Amsterdam University Medical Centers, General Electric (United Kingdom), University Hospital Cologne, Small Woods Association, GenesisCare, University College London, University of Brescia, Vrije Universiteit Amsterdam, University of Gothenburg, Amsterdam UMC Location Vrije Universiteit Amsterdam, KU Leuven
ORCID: 0000-0002-0726-723X
Observed ORCID: 0000-0002-0726-723X
OpenAlex ID: A5079528229
18 F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial
2010 · Rik Vandenberghe, Koen Van Laere, et al. · Annals of Neurology · 646
Quantification of amyloid PET for future clinical use: a state-of-the-art review
2022 · Hugh G. Pemberton, Lyduine E. Collij, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 222
PDF
Centiloid recommendations for clinical context‐of‐use from the AMYPAD consortium
2024 · Lyduine E. Collij, Ariane Bollack, et al. · Alzheimer s & Dementia · 121
PDF
Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection
2016 · Milos D. Ikonomovic, Chris J. Buckley, et al. · Acta Neuropathologica Communications · 98
PDF
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease
2025 · Antoine Leuzy, Ariane Bollack, et al. · Alzheimer s & Dementia · 88
Performance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA‐AA recommendations for the neuropathologic diagnosis of Alzheimer's disease
2017 · Stephen Salloway, Jose E. Gamez, et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 87
PDF
Defining a Centiloid scale threshold predicting long-term progression to dementia in patients attending the memory clinic: an [18F] flutemetamol amyloid PET study
2020 · Bernard J. Hanseeuw, Vincent Malotaux, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 83
PDF
[18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies
2012 · Juha O. Rinne, Dean F. Wong, et al. · Acta Neuropathologica · 82
No Association of Lower Hippocampal Volume With Alzheimer’s Disease Pathology in Late-Life Depression
2016 · François-Laurent De Winter, Louise Emsell, et al. · American Journal of Psychiatry · 80
PDF
Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent
2021 · Lyduine E. Collij, Gemma Salvadó, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 69
PDF
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study
2020 · Isadora Lopes Alves, Lyduine E. Collij, et al. · Alzheimer s & Dementia · 68
PDF
A Systematic Review and Aggregated Analysis on the Impact of Amyloid PET Brain Imaging on the Diagnosis, Diagnostic Confidence, and Management of Patients being Evaluated for Alzheimer’s Disease
2018 · Enrico R. Fantoni, Anastasia Chalkidou, et al. · Journal of Alzheimer s Disease · 68
PDF
The Spatial-Temporal Ordering of Amyloid Pathology and Opportunities for PET Imaging
2019 · Enrico Fantoni, Lyduine Collij, et al. · Journal of Nuclear Medicine · 61
PDF
Pharmacokinetics of [18F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer’s disease
2012 · Anniina Snellman, Johanna Rokka, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 59
Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer’s disease
2020 · Milos D. Ikonomovic, Christopher J. Buckley, et al. · Acta Neuropathologica · 55
PDF
Stress testing the Centiloid: Precision and variability of PET quantification of amyloid pathology
2024 · Mahnaz Shekari, David Vállez García, et al. · Alzheimer s & Dementia · 53
PDF
AMYPAD Diagnostic and Patient Management Study: Rationale and design
2018 · Giovanni B. Frisoni, Frederik Barkhof, et al. · Alzheimer s & Dementia · 53
PDF
Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition
2018 · Dietmar Rudolf Thal, Thomas G. Beach, et al. · Acta Neuropathologica · 53
PDF
Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer’s dementia in mild cognitive impairment patients
2022 · Alexa Pichet Binette, Sebastian Palmqvist, et al. · Alzheimer s Research & Therapy · 52
PDF
A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [18F]flutemetamol amyloid PET images
2021 · Marco Bucci, Irina Savitcheva, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 49
PDF
Longitudinal amyloid and tau PET imaging in Alzheimer's disease: A systematic review of methodologies and factors affecting quantification
2023 · Ariane Bollack, Hugh G. Pemberton, et al. · Alzheimer s & Dementia · 47
PDF
Quantification Supports Amyloid PET Visual Assessment of Challenging Cases: Results from the AMYPAD Diagnostic and Patient Management Study
2024 · Lyduine E. Collij, Gérard N. Bischof, et al. · Journal of Nuclear Medicine · 46
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients
2023 · Daniele Altomare, Frederik Barkhof, et al. · JAMA Neurology · 45
PDF
Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia
2019 · Dietmar Rudolf Thal, Alicja Ronisz, et al. · Acta Neuropathologica Communications · 42
PDF
Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History Study
2024 · Ariane Bollack, Lyduine E. Collij, et al. · Alzheimer s & Dementia · 41
PDF
Works count: 216
Citation count: 3,110
H-index: 30
I10-index: 50
Year
Topic
Type